Most peptide guides give you a textbook. This one names the seven specific things first-time buyers get wrong, before they spend a dollar or pin a needle. We'll cover the steroid mix-up, the dosing trap, the timeline misread, the FDA confusion, the vendor assumption, thereconstitution slip-up, and the bloodwork skip. Read it in under ten minutes. No medical pretending.
Wrong #1: Peptides are basically steroids
This one comes up first in almost every conversation. The answer is no. Steroids are synthetic copies of hormones like testosterone. They flood the body with a powerful signal that lasts for days.
Peptides are short chains of amino acids. They send a narrow signal to a specific receptor, like "release growth hormone" or "heal this tendon." The effect is targeted. The dose is tiny, usually measured in micrograms, not milligrams.
Steroids replace something. Peptides ask the body to do more of what it already does. That is the real difference.
Wrong #2: FDA-approved means always safer
FDA approval means one specific use of one specific drug passed three phases of human trials for that use. It does not mean every other compound is dangerous. Tirzepatide is an FDA-approved prescription drug. The same molecule sold by a research peptide vendor is sold as a research compound, not for human use. Same chemical, two different categories.
Most peptides used in research, like BPC-157, TB-500, and CJC-1295, have decades of published animal data and growing human-trial data. They aren't FDA-approved for retail because the cost of approval is enormous and the patent runway is short. Not because the molecule doesn't work.
Treat the FDA label as one signal, not the only signal. Read the published research. Look at the COA. Ask the vendor where the lot was synthesized.
Wrong #3: More peptide means better results
Almost every beginner overshoots their first dose. The thinking goes: if 5 mg works, 10 mg works twice as well. That is not how peptide receptors work.
Most peptides hit a receptor ceiling. Once you saturate the receptor, more peptide just sits in the bloodstream and gets cleared by the kidneys. Some receptors actually downregulate (turn off) when you push them too hard, so a higher dose can give you less response, not more.
Worse: side effects scale faster than results. Tirzepatide at 5 mg gives most of the weight signal in published trials. At 15 mg, you get a little more weight loss and a lot more nausea. Start at the bottom of the research range. Move up only if you need to.
Wrong #4: Every vendor is roughly the same
They are not. Peptide synthesis is a tricky chemistry process. A poorly run synthesis can produce a vial that is 80% the target peptide and 20% leftover fragments. Some of those fragments can trigger immune responses. Others just do nothing at all.
The only honest signal is a Certificate of Analysis (COA). That is a report from an outside lab, not the vendor itself, confirming the peptide identity and purity. Reputable vendors publish a COA per lot number. Aion does this for every batch.
Cold-chain shipping matters too. Most peptides ship freeze-dried (lyophilized), which makes them more forgiving. But shipping in a Texas summer without an ice pack can still kill potency. Two-day shipping with a gel pack is the minimum standard.
Wrong #5: Reconstitution is just adding water
Almost. The water type matters. Most research peptides reconstitute in bacteriostatic water(sterile water with 0.9% benzyl alcohol). The alcohol keeps bacteria from growing in the vial after you start using it. Plain sterile water works for a single use but goes bad fast.
Technique matters too. Don't shake the vial. Tilt and swirl it gently until the powder dissolves. Shaking can break the peptide chain and reduce potency.
Once mixed, store the vial in the fridge at 36 to 46 degrees. Most reconstituted peptides stay stable for 30 to 60 days. We have a step-by-step guide at /blog/how-to-reconstitute-peptides if you want the full walk-through.
Wrong #6: You'll see results in a week
Depends on the peptide. Repair peptides like BPC-157 can show a signal in 1 to 3 weeks for joint or tendon issues. Some people feel it sooner.
Growth hormone peptides like CJC-1295 and Ipamorelin work on a slower clock. Most users need 8 to 12 weeks of consistent nightly dosing to notice sleep, recovery, or body comp changes.
Weight peptides like Tirzepatide and Retatrutide are in between. Published research shows weight signal in the first 2 to 4 weeks, with the bigger drops landing between weeks 12 and 24. Don't quit at week 2 because you didn't lose 10 pounds. That is not how the molecule works.
Wrong #7: Bloodwork is optional
Bloodwork before you start gives you a baseline. Without a baseline, you cannot tell what changed.
For most peptides, a basic panel (lipids, complete blood count, metabolic panel) is enough. For weight peptides in the GLP-1 class, also pull HbA1c and fasting glucose. For growth hormone peptides, IGF-1 is the standard tracking marker.
Re-pull labs every 8 to 12 weeks while you're running a compound. If a marker moves in a bad direction, you'll catch it early. None of this is medical advice. Talk to a clinician who can read your numbers in context.
What to actually do next
Pick one compound. Not three. Not six. Pick the one that targets your single biggest goal: recovery, growth hormone signal, or weight.
Order from a vendor that publishes a COA per lot. Reconstitute with bacteriostatic water and swirl, don't shake. Start at the bottom of the research range. Track bloodwork at week 0, then every 8 to 12 weeks after.
If you read this far, you're already ahead of 90% of beginners. Find your protocol next, or read more about reconstitution and injection technique below.